A method of treating a proliferative disorder, and a pharmaceutical composition for use in such a method, comprises administering to the patient a combination of an agonist of a death receptor and an antagonist of Egr-1. The death receptor agonist and the Egr-1 antagonist may be administered sequentially, separately or in combination

Treatment of proliferative disorders with a death receptor agonist / Samali, Afshin; Szegezdi, Eva; Mahalingam, Devalingam; Natoni, Alessandro. - (2009).

Treatment of proliferative disorders with a death receptor agonist

Alessandro Natoni
Investigation
2009

Abstract

A method of treating a proliferative disorder, and a pharmaceutical composition for use in such a method, comprises administering to the patient a combination of an agonist of a death receptor and an antagonist of Egr-1. The death receptor agonist and the Egr-1 antagonist may be administered sequentially, separately or in combination
2009
Egr1; Death receptors; Leukemia; TRAIL
05 Brevetto::05a Brevetto
Treatment of proliferative disorders with a death receptor agonist / Samali, Afshin; Szegezdi, Eva; Mahalingam, Devalingam; Natoni, Alessandro. - (2009).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1674073
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact